CareLit · DOI-Nachweis · Senologie - Zeitschrift für Mammadiagnostik und -therapie
Prospective evaluation of cardiac safety in breast cancer patients after adjuvant treatment with epirubicin, cyclophosphamide, doxetaxel and with or without trastuzumab: A single center experience
DOI 10.1055/s-0035-1550557
Bibliografische Angaben
Nachweis in CareLit
Autor:innenJ Puppe, D van Ooyen, J Neise, F Thangarajah, C Eichler, R Pfister, S Krämer, P Mallmann, M Wirtz, G Michels
ZeitschriftSenologie - Zeitschrift für Mammadiagnostik und -therapie
Ausgabe05/2015
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background: Anticancer drugs can cause cardiotoxicity. Chemotherapy with antracyclines is associated with electrocardiographic alterations. Among the targeted therapies QTc aberrations were reported upon treatment with the anti HER2/neu antibody trastuzumab. Methods: In this observational study we assessed the cardiac safety in 19 adjuvant treated breast cancer patients. All 9 HER2/neu positive breast cancer patient…
Zitieren
Zitierempfehlung
J Puppe, D van Ooyen, J Neise, F Thangarajah, C Eichler, R Pfister, S Krämer, P Mallmann, M Wirtz, G Michels (2015) Prospective evaluation of cardiac safety in breast cancer patients after adjuvant treatment with epirubicin, cyclophosphamide, doxetaxel and with or without trastuzumab: A single center experience. Senologie - Zeitschrift für Mammadiagnostik und -therapie (05). https://doi.org/10.1055/s-0035-1550557
Mit CareLit weiterarbeiten